Logo image of EXPL.PA

EXPLOSIFS PROD. CHI (EXPL.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:EXPL - FR0014003AQ4 - Common Stock

218 EUR
-8 (-3.54%)
Last: 11/28/2025, 7:00:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EXPL. EXPL was compared to 74 industry peers in the Chemicals industry. While EXPL has a great profitability rating, there are some minor concerns on its financial health. EXPL has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year EXPL was profitable.
In the past year EXPL had a positive cash flow from operations.
EXPL had positive earnings in 4 of the past 5 years.
EXPL had a positive operating cash flow in each of the past 5 years.
EXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFEXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

EXPL has a Return On Assets of 4.98%. This is in the better half of the industry: EXPL outperforms 70.27% of its industry peers.
With an excellent Return On Equity value of 14.04%, EXPL belongs to the best of the industry, outperforming 81.08% of the companies in the same industry.
EXPL has a better Return On Invested Capital (6.36%) than 64.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EXPL is in line with the industry average of 6.48%.
The 3 year average ROIC (6.01%) for EXPL is below the current ROIC(6.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROIC 6.36%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
EXPL.PA Yearly ROA, ROE, ROICEXPL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Profit Margin of EXPL (4.77%) is better than 62.16% of its industry peers.
In the last couple of years the Profit Margin of EXPL has grown nicely.
Looking at the Operating Margin, with a value of 4.22%, EXPL is in line with its industry, outperforming 47.30% of the companies in the same industry.
EXPL's Operating Margin has improved in the last couple of years.
EXPL has a better Gross Margin (60.41%) than 90.54% of its industry peers.
In the last couple of years the Gross Margin of EXPL has grown nicely.
Industry RankSector Rank
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
EXPL.PA Yearly Profit, Operating, Gross MarginsEXPL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EXPL is destroying value.
The number of shares outstanding for EXPL has been increased compared to 1 year ago.
Compared to 5 years ago, EXPL has more shares outstanding
EXPL has a better debt/assets ratio than last year.
EXPL.PA Yearly Shares OutstandingEXPL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
EXPL.PA Yearly Total Debt VS Total AssetsEXPL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

EXPL has an Altman-Z score of 2.77. This is not the best score and indicates that EXPL is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.77, EXPL is doing good in the industry, outperforming 63.51% of the companies in the same industry.
The Debt to FCF ratio of EXPL is 2.38, which is a good value as it means it would take EXPL, 2.38 years of fcf income to pay off all of its debts.
EXPL has a Debt to FCF ratio of 2.38. This is amongst the best in the industry. EXPL outperforms 90.54% of its industry peers.
EXPL has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
EXPL has a Debt to Equity ratio (0.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Altman-Z 2.77
ROIC/WACC0.84
WACC7.58%
EXPL.PA Yearly LT Debt VS Equity VS FCFEXPL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

EXPL has a Current Ratio of 1.26. This is a normal value and indicates that EXPL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EXPL (1.26) is worse than 75.68% of its industry peers.
A Quick Ratio of 0.94 indicates that EXPL may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.94, EXPL is in line with its industry, outperforming 40.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
EXPL.PA Yearly Current Assets VS Current LiabilitesEXPL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 14.37% over the past year.
The Earnings Per Share has been growing by 51.47% on average over the past years. This is a very strong growth
EXPL shows a small growth in Revenue. In the last year, the Revenue has grown by 5.49%.
Measured over the past years, EXPL shows a small growth in Revenue. The Revenue has been growing by 7.27% on average per year.
EPS 1Y (TTM)14.37%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%9.14%
Revenue 1Y (TTM)5.49%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%7.52%

3.2 Future

The Earnings Per Share is expected to grow by 16.53% on average over the next years. This is quite good.
EXPL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.20% yearly.
EPS Next Y7.4%
EPS Next 2Y19.69%
EPS Next 3Y16.53%
EPS Next 5YN/A
Revenue Next Year6.67%
Revenue Next 2Y6.51%
Revenue Next 3Y5.2%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EXPL.PA Yearly Revenue VS EstimatesEXPL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
EXPL.PA Yearly EPS VS EstimatesEXPL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 18.83, which indicates a rather expensive current valuation of EXPL.
Based on the Price/Earnings ratio, EXPL is valued a bit cheaper than 66.22% of the companies in the same industry.
When comparing the Price/Earnings ratio of EXPL to the average of the S&P500 Index (26.31), we can say EXPL is valued slightly cheaper.
With a Price/Forward Earnings ratio of 12.41, EXPL is valued correctly.
EXPL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. EXPL is cheaper than 71.62% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 36.59. EXPL is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 18.83
Fwd PE 12.41
EXPL.PA Price Earnings VS Forward Price EarningsEXPL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150 200 250

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXPL is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EXPL indicates a rather cheap valuation: EXPL is cheaper than 89.19% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 12.14
EV/EBITDA 11.76
EXPL.PA Per share dataEXPL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EXPL does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of EXPL may justify a higher PE ratio.
EXPL's earnings are expected to grow with 16.53% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.54
PEG (5Y)N/A
EPS Next 2Y19.69%
EPS Next 3Y16.53%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.66%, EXPL is not a good candidate for dividend investing.
EXPL's Dividend Yield is slightly below the industry average, which is at 3.15.
Compared to an average S&P500 Dividend Yield of 2.34, EXPL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.66%

5.2 History

The dividend of EXPL decreases each year by -6.39%.
Dividend Growth(5Y)-6.39%
Div Incr Years1
Div Non Decr Years1
EXPL.PA Yearly Dividends per shareEXPL.PA Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.5 1

5.3 Sustainability

9.03% of the earnings are spent on dividend by EXPL. This is a low number and sustainable payout ratio.
DP9.03%
EPS Next 2Y19.69%
EPS Next 3Y16.53%
EXPL.PA Yearly Income VS Free CF VS DividendEXPL.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M
EXPL.PA Dividend Payout.EXPL.PA Dividend Payout, showing the Payout Ratio.EXPL.PA Dividend Payout.PayoutRetained Earnings

EXPLOSIFS PROD. CHI

EPA:EXPL (11/28/2025, 7:00:00 PM)

218

-8 (-3.54%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)11-13 2025-11-13
Earnings (Next)N/A N/A
Inst Owners3.75%
Inst Owner ChangeN/A
Ins Owners0.42%
Ins Owner ChangeN/A
Market Cap492.68M
Revenue(TTM)508.38M
Net Income(TTM)23.37M
Analysts82.86
Price Target221.34 (1.53%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.66%
Yearly Dividend1
Dividend Growth(5Y)-6.39%
DP9.03%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-10.66%
EPS NY rev (3m)-10.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.47%
Revenue NY rev (3m)3.35%
Valuation
Industry RankSector Rank
PE 18.83
Fwd PE 12.41
P/S 1.01
P/FCF 12.14
P/OCF 7.34
P/B 2.96
P/tB 3.29
EV/EBITDA 11.76
EPS(TTM)11.58
EY5.31%
EPS(NY)17.56
Fwd EY8.06%
FCF(TTM)17.96
FCFY8.24%
OCF(TTM)29.69
OCFY13.62%
SpS216.88
BVpS73.67
TBVpS66.32
PEG (NY)2.54
PEG (5Y)N/A
Graham Number138.54
Profitability
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROCE 7.48%
ROIC 6.36%
ROICexc 6.41%
ROICexgc 6.82%
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
FCFM 8.28%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
ROICexc(3y)6.49%
ROICexc(5y)5.43%
ROICexgc(3y)6.91%
ROICexgc(5y)5.79%
ROCE(3y)7.04%
ROCE(5y)5.85%
ROICexgc growth 3Y2.1%
ROICexgc growth 5Y14.44%
ROICexc growth 3Y2.48%
ROICexc growth 5Y15.88%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Debt/EBITDA 1.33
Cap/Depr 91.37%
Cap/Sales 5.41%
Interest Coverage 3.37
Cash Conversion 135.01%
Profit Quality 173.71%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.77
F-Score6
WACC7.58%
ROIC/WACC0.84
Cap/Depr(3y)105.91%
Cap/Depr(5y)86.48%
Cap/Sales(3y)5.43%
Cap/Sales(5y)5.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.37%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%9.14%
EPS Next Y7.4%
EPS Next 2Y19.69%
EPS Next 3Y16.53%
EPS Next 5YN/A
Revenue 1Y (TTM)5.49%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%7.52%
Revenue Next Year6.67%
Revenue Next 2Y6.51%
Revenue Next 3Y5.2%
Revenue Next 5YN/A
EBIT growth 1Y22.43%
EBIT growth 3Y16.9%
EBIT growth 5Y23.09%
EBIT Next Year88.7%
EBIT Next 3Y32.83%
EBIT Next 5YN/A
FCF growth 1Y284.59%
FCF growth 3Y49.53%
FCF growth 5Y77.86%
OCF growth 1Y102.52%
OCF growth 3Y33.74%
OCF growth 5Y25.45%

EXPLOSIFS PROD. CHI / EXPL.PA FAQ

What is the ChartMill fundamental rating of EXPLOSIFS PROD. CHI (EXPL.PA) stock?

ChartMill assigns a fundamental rating of 6 / 10 to EXPL.PA.


Can you provide the valuation status for EXPLOSIFS PROD. CHI?

ChartMill assigns a valuation rating of 6 / 10 to EXPLOSIFS PROD. CHI (EXPL.PA). This can be considered as Fairly Valued.


Can you provide the profitability details for EXPLOSIFS PROD. CHI?

EXPLOSIFS PROD. CHI (EXPL.PA) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for EXPL stock?

The Price/Earnings (PE) ratio for EXPLOSIFS PROD. CHI (EXPL.PA) is 18.83 and the Price/Book (PB) ratio is 2.96.


Can you provide the financial health for EXPL stock?

The financial health rating of EXPLOSIFS PROD. CHI (EXPL.PA) is 5 / 10.